Trump's tariff reduction rhetoric and China's economic data seem to signal a positive outlook for the FLCH ETF, despite political risks. FLCH's lower expense ratio and better diversification make it a strong representative of the Chinese market. There seems to have been more trade destabilization in the U.S. than in China following the implementation of tariffs, as suggested by the countries' import-export reports.

Washington and Beijing agreed over the weekend in Switzerland to slash sky high tariff rates by 115%, U.S. Treasury Secretary Scott Bessent said Monday. Oil prices had plunged the lowest level in four years earlier this month as President Donald Trump's global tariff regime raised the risk of a recession that would slow demand.

NRG Energy has agreed to acquire LS Power's portfolio of natural gas generation facilities and power plant platform in a cash-and-stock deal with an enterprise value of about $12 billion.

TAMPA, FL / ACCESS Newswire / May 12, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX, "Wellgistics Health"), a healthcare infrastructure and pharmaceutical distribution company leveraging proprietary technology, today announced financial results for its first fiscal quarter ended March 31, 2025. Revenue for the Q1 2025 quarter increased to $10.86 million from zero during the comparable period last year on a GAAP basis.

TEL AVIV, Israel, May 12, 2025 (GLOBE NEWSWIRE) -- HUB Cyber Security Ltd. (Nasdaq: HUBC) (“HUB” or the “Company”), a developer of confidential computing cybersecurity solutions and services, today announced a series of new customer wins through its cybersecurity division, further expanding its footprint in high-risk, regulated industries including healthcare, financial services, and digital infrastructure.

Amazon was outstripping its Magnificent Seven peers such as Microsoft, Alphabet and Meta Platforms as the market welcomed news of a U.S.-China truce on tariffs.

HP anticipates capital expenditures to be in the range of $360-$395 million for fiscal 2025, accompanied by approximately $595 million in depreciation and amortization expenses.

Doximity's Q4 performance likely witnessed strong product-driven gains from new modules and integrated programs, though early revenue pull-forward might have tempered sequential growth.

Enjoy your retirement years without financial worries by collecting income from the market. Harvest dollars and discover the opportunities that come with them. Tired of fear, uncertainty, and doubt? Sow income and watch them disappear.

– ATH434 Phase 2 data demonstrated clinically meaningful efficacy on multiple clinical endpoints – – MSA Atrophy Index (MSAai) enhances MSA diagnosis and monitoring – – bioMUSE Study shows higher α- synuclein concentration is associated with greater burden of orthostatic symptoms – MELBOURNE, Australia and SAN FRANCISCO, May 12, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that several oral and poster presentations related to Alterity's clinical programs in Multiple System Atrophy (MSA) were featured at the 2025 International MSA …

Texas Back Institute is a world leader in advancing spine technology, science, and education, as well as patient care CLARITY is a randomized clinical trial designed to demonstrate Nociscan's ability to improve surgical outcomes for chronic low back pain Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) BROOMFIELD, Colo., May 12, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic …

BELO HORIZONTE, Brazil, May 12, 2025 (GLOBE NEWSWIRE) -- Inter&Co Inc. (NASDAQ: INTR | B3: INBR32), the leading financial super app providing financial and digital commerce services to 37.7 million customers, today reported financial results for the first quarter of 2025.

CATL is raising money on the Hong Kong Stock Exchange, giving more investors access to the fast-growing battery maker.

Amazon stock outperformed the S&P 500 since my January "Buy" call, rising 24.68% versus 16.5%, with recent dips offering an attractive entry point due to strong fundamentals and reduced valuation. Q1 results validated Amazon's business expansion, with sales up 8.62% YoY, EBIT up 20%, and non-GAAP EPS surging 62%, beating consensus by 16.7%, driven by AWS and cost control. Amazon Ads now contributes nearly 9% of revenue, growing 19% YoY, while AWS's 17% YoY growth and heavy AI infrastructure investment signal robust future monetization and cloud dominance.

G-III offers strong potential through its focus on high-margin owned brands, global expansion, digital innovation and solid brand performance.

NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Apple Inc. ("Apple Inc.") (NASDAQ:AAPL) concerning possible violations of federal securities laws. Apple announced its upcoming release of the new iPhone 16 and 16 Plus models on June 10, 2024.

NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Capricor Therapeutics, Inc. ("Capricor Therapeutics, Inc.") (NASDAQ:CAPR) concerning possible violations of federal securities laws. Capricor issued a press release on May 5, 2025, announcing that after "the completion of a mid-cycle review meeting with the U.S. Food and Drug Administration (FDA) for the Company's Biologics License Application (BLA) seeking full approval for deramiocel, an investigational cell therapy, as a treatment for patients diagnosed with Duchenne muscular dystrophy (DMD) cardiomyopathy", the FDA had "confirmed its intent to hold …

NEW YORK, NY / ACCESS Newswire / May 12, 2025 / If you suffered a loss on your Perpetua Resources Corp. (NASDAQ:PPTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/perpetua-resources-corp-lawsuit-submission-form?prid=147999&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 12, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=148000&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Ardelyx, Inc. ("Ardelyx, Inc.") (NASDAQ:ARDX) concerning possible violations of federal securities laws. Ardelyx issued a press release on May 1, 2025, reporting its financial results for the first quarter of 2025.